School of Chemical Engineering, Yeungnam University, Gyeongsan, Republic of Korea.
Biotechnol Lett. 2012 Apr;34(4):655-61. doi: 10.1007/s10529-011-0825-z. Epub 2011 Dec 11.
Bacterial biofilms are associated with chronic infections due to their resistance to antimicrobial agents. Staphylococcus aureus is a versatile human pathogen and can form biofilms on human tissues and diverse medical devices. To identify novel biofilm inhibitors of S. aureus, the supernatants from a library of 458 Actinomycetes strains were screened. The culture supernatants (1% v/v) of more than 10 Actinomycetes strains inhibited S. aureus biofilm formation by more than 80% without affecting the growth. The culture supernatants of these biofilm-reducing Actinomycetes strains contained a protease (equivalent to 0.1 μg proteinase K ml(-1)), which both inhibited S. aureus biofilm formation and detached pre-existing S. aureus biofilms. This study suggests that protease treatment could be a feasible tool to reduce and eradicate S. aureus biofilms.
细菌生物膜因其对抗菌药物的抵抗力而与慢性感染有关。金黄色葡萄球菌是一种多功能的人类病原体,可在人体组织和各种医疗设备上形成生物膜。为了鉴定金黄色葡萄球菌的新型生物膜抑制剂,从 458 株放线菌库中筛选了上清液。超过 10 株放线菌的培养上清液(1%v/v)抑制了金黄色葡萄球菌生物膜形成,抑制率超过 80%,而不影响生长。这些减少生物膜形成的放线菌菌株的培养上清液含有一种蛋白酶(相当于 0.1μg 蛋白酶 K/ml),它既能抑制金黄色葡萄球菌生物膜的形成,又能使已存在的金黄色葡萄球菌生物膜脱落。本研究表明,蛋白酶处理可能是减少和清除金黄色葡萄球菌生物膜的一种可行方法。